Literature DB >> 9791159

Liver transplantation as definitive therapy for complications after arterial embolization for hepatic manifestations of hereditary hemorrhagic telangiectasia.

J S Odorico1, M N Hakim, Y T Becker, W Van der Werf, A Musat, S J Knechtle, A M D'Alessandro, M Kalayoglu.   

Abstract

Experience with hepatic artery embolization for the treatment of symptomatic hepatic arteriovenous malformations (AVMs) in Rendu-Osler-Weber disease is limited. We report 2 cases of hepatic AVMs that caused mesenteric angina-like symptoms that were treated with embolization. Both patients developed parenchymal and bile duct necrosis, intrahepatic bilomas, and refractory biliary sepsis, subsequently leading to liver failure. We hypothesize that the pathophysiological cause of biliary necrosis in this setting is similar to that which occurs in the setting of hepatic artery thrombosis of the liver allograft. Progressive liver failure in these patients was treated successfully by liver transplantation. Liver transplantation offers definitive therapy by removing the source of ongoing sepsis, restoring normal liver function, and eliminating the intrahepatic AV shunt.

Entities:  

Mesh:

Year:  1998        PMID: 9791159     DOI: 10.1002/lt.500040609

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  6 in total

1.  Successful liver transplantation for Rendu-Weber-Osler disease, a single centre experience.

Authors:  Murat Cag; Maxime Audet; Anne-Catherine Saouli; Murad Odeh; Bernard Ellero; Tullio Piardi; Marie-Lorraine Woehl-Jaeglé; Jacques Cinqualbre; Philippe Wolf
Journal:  Hepatol Int       Date:  2011-02-17       Impact factor: 6.047

2.  Preoperative arterial embolization of large liver hemangiomas.

Authors:  Serdar Topaloğlu; Şükrü Oğuz; Orhan Kalaycı; M Halil Öztürk; Adnan Çalık; Hasan Dinç; Ümit Çobanoğlu
Journal:  Diagn Interv Radiol       Date:  2015 May-Jun       Impact factor: 2.630

3.  Liver transplantation for hereditary hemorrhagic telangiectasia: Report of the European liver transplant registry.

Authors:  Jan Lerut; Giuseppe Orlando; René Adam; Carlo Sabbà; Robert Pfitzmann; Jurgen Klempnauer; Jacques Belghiti; Jacques Pirenne; Thierry Thevenot; Christian Hillert; Colin M Brown; Dominique Gonze; Vincent Karam; Olivier Boillot
Journal:  Ann Surg       Date:  2006-12       Impact factor: 12.969

4.  Hepatic artery embolization for treatment of patients with hereditary hemorrhagic telangiectasia and symptomatic hepatic vascular malformations.

Authors:  Ajay Chavan; Martin Caselitz; Karl-Friedrich Gratz; Joachim Lotz; Timm Kirchhoff; Plinio Piso; Siegfried Wagner; Michael Manns; Michael Galanski
Journal:  Eur Radiol       Date:  2004-08-17       Impact factor: 5.315

5.  Treatment of high output cardiac failure by flow-adapted hepatic artery banding (FHAB) in patients with hereditary hemorrhagic telangiectasia.

Authors:  A Koscielny; W A Willinek; A Hirner; M Wolff
Journal:  J Gastrointest Surg       Date:  2007-11-20       Impact factor: 3.452

Review 6.  Perioperative Complications and Long-Term Follow-Up of Liver Transplantation in Hemorrhagic Hereditary Telangiectasia: Report of Three Cases and Systematic Review.

Authors:  Antoni Riera-Mestre; Pau Cerdà; Yoelimar Carolina Guzmán; Adriana Iriarte; Alba Torroella; José María Mora-Luján; Jose Castellote; Amelia Hessheimer; Constantino Fondevila; Laura Lladó
Journal:  J Clin Med       Date:  2022-09-24       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.